Treatment of CML CD34+ cells with EZH2 inhibitor GSK343
收藏官方服务：
资源简介：
Treatment of CML CD34+ cells with EZH2 inhibitor GSK343
应用场景：
创建时间：
2016-11-01
相关数据集
Gene expression changes in HEK293T cells upon overexpression of ING1b and GADD45a. Homo sapiens
ING1b and GADD45a are nuclear proteins involved in the regulation of cell growth, apoptosis and DNA repair. We found that ING1b and GADD45a physically and functionally interact in the epigenetic regul
NIAID Data Ecosystem30
TF ChIP-seq from whole organism (ENCSR857HWD)
ChIP-seq on transgenic worms expressing F57A8.1-eGFP fusion proteins. The IP was performed using an anti-GFP antibody. For data usage terms and conditions, please refer to http://www.genome.gov/27528
NIAID Data Ecosystem30
DataSheet_1_Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France.docx
We analyzed demographic characteristics, comorbidities and patterns of treatment with tyrosine kinase inhibitors (TKIs) in a cohort of 3,633 incident cases of chronic myeloid leukemia (CML) identified
NIAID Data Ecosystem30
Primers used in the DNA methylation analysis.
1Bold symbol represents the amplicons with good quality.2No. of CpG site = the number of CpG sites in each amplicon.
Figshare2015-12-02 更新30
Discovery of CZS-241: A Potent, Selective, and Orally Available Polo-Like Kinase 4 Inhibitor for the Treatment of Chronic Myeloid Leukemia
Recent studies demonstrate that PLK4 has emerged as a therapeutic target for the treatment of multiple cancers owing to its indispensable role in cell division. Herein, starting from previously identi
NIAID Data Ecosystem30
